Buy Pramipex ER 0.75 Pramipexole Dihydrochloride

Pramipex ER 0.75 (Pramipexole Dihydrochloride) is a long-acting tablet used for managing symptoms of Parkinson’s disease and restless legs syndrome. This extended-release formulation provides steady medication levels over 24 hours. Pramipex ER 0.75mg offers convenient once-daily dosing for sustained symptom control.

Strength

0.75mg

Pack Size

50s

Storage

15-25°

Manufacturer / TM Owner

Sun Pharma Laboratories Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Pramipex ER 0.75 is prescribed to help reduce symptoms associated with Parkinson’s disease, such as tremors, stiffness, and slowed movement. It is also used to treat moderate to severe restless legs syndrome, providing relief from the urge to move the legs and associated discomfort. This medication works by influencing dopamine activity in the brain.

Side Effects

Pramipex ER 0.75 may help improve motor function and reduce restlessness when taken as directed. Some users report better sleep quality and reduced daytime drowsiness. Effects can vary, and it may take time to notice the full benefits. Common effects include mild nausea or dizziness, especially when starting treatment.

Precautions & Warnings

Store Pramipex ER 0.75 at room temperature, away from moisture and direct light. Keep the medication in its original packaging until ready to use. Do not crush, chew, or split the extended-release tablet, as this can affect how the drug is absorbed. Always follow the handling instructions provided with the product.

Avoid Interactions

Pramipex ER 0.75 may interact with medications that affect dopamine levels or central nervous system activity. Alcohol and sedatives can increase drowsiness when taken together. Inform your healthcare provider about all prescription, over-the-counter, and herbal products you are using to avoid potential interactions.

References

Frequently Asked Questions

Pramipex ER 0.75 is used to treat symptoms of Parkinson’s disease and restless legs syndrome.

Store at room temperature (15–25°C) in a dry place away from light.

It can be taken with or without food, but consistency in timing is recommended.

Common effects may include nausea, dizziness, or drowsiness, especially when starting treatment.

Pramipex ER 0.75 is an extended-release tablet designed for once-daily dosing.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.